Ekso Bionics Holdings, Inc.
EKSO
$3.84
-$0.025-0.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.38M | 5.09M | 4.13M | 4.95M | 3.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.38M | 5.09M | 4.13M | 4.95M | 3.76M |
| Cost of Revenue | 1.57M | 2.38M | 1.92M | 2.31M | 1.81M |
| Gross Profit | 1.81M | 2.71M | 2.21M | 2.64M | 1.95M |
| SG&A Expenses | 4.08M | 4.69M | 4.07M | 3.86M | 4.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.64M | 7.32M | 6.77M | 7.29M | 7.01M |
| Operating Income | -3.26M | -2.23M | -2.64M | -2.34M | -3.26M |
| Income Before Tax | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M |
| EBIT | -3.26M | -2.23M | -2.64M | -2.34M | -3.26M |
| EBITDA | -2.88M | -1.83M | -2.23M | -1.94M | -2.85M |
| EPS Basic | -1.71 | -2.08 | -1.53 | -1.99 | -2.95 |
| Normalized Basic EPS | -1.00 | -1.30 | -0.96 | -1.24 | -1.79 |
| EPS Diluted | -1.71 | -2.08 | -1.53 | -1.99 | -2.95 |
| Normalized Diluted EPS | -1.00 | -1.30 | -0.96 | -1.24 | -1.79 |
| Average Basic Shares Outstanding | 1.69M | 1.64M | 1.35M | 1.21M | 1.16M |
| Average Diluted Shares Outstanding | 1.69M | 1.64M | 1.35M | 1.21M | 1.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |